While the metformin-treated Ob-NAFLD group (Ob-NAFLD + M) resulted in a modest reduction in these apoptotic markers, the changes did not reach statistical significance ( Figure 7 D–F).
← all excerpts
Obesity-Associated NAFLD Coexists with a Chronic Inflammatory Kidney Condition That Is Partially Mitigated by Short-Term Oral Metformin.
1
—
—